AMD
Advanced Micro Devices, Inc.
AMD has the edge over DOCN overall, supported by stronger modeled upside and lower modeled downside.
DOCN
DigitalOcean Holdings, Inc.
DOCN trails on the overall score without a compensating advantage in the available component scores.
AMD Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
AMD's revenue, profitability, cash flow and balance sheet are all currently strong.
DOCN Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Strong | |
| Strong |
DOCN's revenue, cash flow and balance sheet are currently strong, and its profitability is stable.
AMD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 39x | $585 | — |
| Cheap | 40x | $182 | -69% |
| Fair | 112x | $514 | -12% |
| Current | 127x | $585 | — |
| Expensive | 206x | $947 | +62% |
Historical ranges are pointers, not guarantees.
AMD has the edge over DOCN in the historical PE scenario, which offers more potential upside but is not a forecast.
DOCN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 25x | $7.61 | -92% |
| Fair | 46x | $13.68 | -85% |
| Forward | 55x | $90.07 | — |
| Expensive | 68x | $20.36 | -77% |
| Current | 300x | $90.07 | — |
Historical ranges are pointers, not guarantees.
DOCN's PE is in its expensive range at 300x. If earnings grow as analysts expect, today's price would be 55x next year's earnings, in its fair range.
AMD Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Low |
AMD has the edge over DOCN on the outlook, with more favorable profitability expectations.
DOCN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for DOCN, but weaker profitability. However, they disagree widely on these estimates.
AMD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $15.05 | +227% |
| Q3 2026 | $4.60 | +127% |
| Q2 2026 | $3.89 | +122% |
| Q1 2026 | $3.05 | +123% |
| Q4 2025 | $2.65 | +165% |
| Q3 2025 | $2.03 | +81% |
| Q2 2025 | $1.75 | +111% |
| Q1 2025 | $1.37 | +99% |
| Q4 2024 | $1.00 | +89% |
AMD has the edge over DOCN on earnings, with more consistent year-over-year improvement.
DOCN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.64 | +448% |
| Q3 2026 | $0.30 | -88% |
| Q2 2026 | $2.18 | +68% |
| Q1 2026 | $2.28 | +105% |
| Q4 2025 | $2.52 | +190% |
| Q3 2025 | $2.48 | +195% |
| Q2 2025 | $1.30 | +83% |
| Q1 2025 | $1.11 | +113% |
| Q4 2024 | $0.87 | +335% |
DOCN earned $0.30 per share over the past year, down 88% from the year before.
AMD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $13.4B | +45% |
| Q2 2026 | $11.5B | +50% |
| Q1 2026 | $10.3B | +38% |
| Q4 2025 | $10.3B | +34% |
| Q3 2025 | $9.2B | +36% |
| Q2 2025 | $7.7B | +32% |
| Q1 2025 | $7.4B | +36% |
| Q4 2024 | $7.7B | +24% |
AMD has the edge over DOCN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 21% | +7.4 points |
| Q2 2026 | 17% | +19 points |
| Q1 2026 | 14% | +3.6 points |
| Q4 2025 | 17% | +5.7 points |
| Q3 2025 | 14% | +3.1 points |
| Q2 2025 | -1.7% | -6.4 points |
| Q1 2025 | 11% | +10 points |
| Q4 2024 | 11% | +5.8 points |
AMD has the edge over DOCN on profitability, with a higher operating margin.
DOCN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $321.2M | +40% |
| Q2 2026 | $281.2M | +29% |
| Q1 2026 | $257.9M | +22% |
| Q4 2025 | $242.4M | +18% |
| Q3 2025 | $229.6M | +16% |
| Q2 2025 | $218.7M | +14% |
| Q1 2025 | $210.7M | +14% |
| Q4 2024 | $204.9M | +13% |
DOCN's revenue has grown year over year every quarter since early 2021: $321M last quarter, up 40% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 10% | -9.3 points |
| Q2 2026 | 10% | -5.8 points |
| Q1 2026 | 14% | -3.7 points |
| Q4 2025 | 16% | +0.1 points |
| Q3 2025 | 20% | +7.2 points |
| Q2 2025 | 16% | +4.7 points |
| Q1 2025 | 18% | +12 points |
| Q4 2024 | 16% | +9.8 points |
DOCN's operating margin was 10% last quarter, down 9.3 points from the same quarter a year ago.
AMD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $554M | -71% |
| Q2 2026 | $1.6B | -9.9% |
| Q1 2026 | $2.6B | +253% |
| Q4 2025 | $2.4B | +118% |
| Q3 2025 | $1.9B | +283% |
| Q2 2025 | $1.7B | +294% |
| Q1 2025 | $727M | +92% |
| Q4 2024 | $1.1B | +351% |
AMD has the edge over DOCN on cash flow, with stronger typical year-over-year growth.
DOCN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $137.7M | +56% |
| Q2 2026 | $68.4M | +15% |
| Q1 2026 | $6.9M | +226% |
| Q4 2025 | $31.1M | +19% |
| Q3 2025 | $88M | +450% |
| Q2 2025 | $59.3M | +50% |
| Q1 2025 | $2.1M | -91% |
| Q4 2024 | $26.1M | -7.9% |
DOCN generated $244M in free cash flow over the past year, up 39% from the year before.
AMD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +2M shares |
| 1 year | +1.2% | +20M shares |
| 3 years | +2% | +32M shares |
| 5 years | +35% | +431M shares |
| Available history | +40% | +473M shares |
AMD has the edge over DOCN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $221M |
| Q4 2025 | — |
| Q3 2025 | $89M |
| Q2 2025 | $478M |
| Q1 2025 | $749M |
| Q4 2024 | $256M |
AMD has spent almost nothing on buybacks in the past year.
DOCN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -9.4% | -11.9M shares |
| 1 year | +8.7% | +9.2M shares |
| 3 years | +12% | +12M shares |
| 5 years | +6.2% | +6.7M shares |
| Available history | +32% | +27.6M shares |
DOCN has 115M diluted shares, up 8.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $2.9M |
| Q2 2025 | $20.1M |
| Q1 2025 | $59.1M |
| Q4 2024 | $29.9M |
DOCN hasn't bought back shares in the past year.
AMD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2020 | -1.0x | Net Cash |
| Q1 2020 | -0.8x | Net Cash |
| Q4 2019 | -1.2x | Net Cash |
AMD has more cash than debt.
DOCN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.6x | Net Cash |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 3.5x | Elevated |
| Q3 2025 | 3.8x | Elevated |
| Q2 2025 | 4.3x | High |
| Q1 2025 | 4.6x | High |
| Q4 2024 | 4.8x | High |
DOCN has more cash than debt.
AMD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.3 | Neutral |
| Stochastic | 41.4 | Neutral |
AMD's weekly RSI is 59 (neutral) and its Stochastic is 41 (neutral).
DOCN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.1 | Neutral |
| Stochastic | 11.0 | Oversold |
DOCN's weekly RSI is 42 (neutral) and its Stochastic is 11 (oversold).
AMD PE vs Technology Sector
| Metric | AMD | Sector median | Relative |
|---|---|---|---|
| PE | 127x | 28x | 357% above |
| PE % | 61 | 35 | 26 pts above |
AMD has the edge over DOCN on valuation relative to its sector.
DOCN PE vs Technology Sector
| Metric | DOCN | Sector median | Relative |
|---|---|---|---|
| PE | 300x | 28x | 978% above |
| PE % | 100 | 41 | 59 pts above |
DOCN is trading at 300x earnings, a 978% premium to the Technology sector's median of 28x.
AMD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $557.2 | 5.1% above |
| 20 week MA | $525.9 | 11% above |
| 50 week MA | $389.7 | 50% above |
| 100 week MA | $266.9 | 119% above |
| 200 week MA | $199.6 | 193% above |
AMD has the edge over DOCN on trend strength, trading above more of its moving averages.
DOCN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $107.3 | 16% below |
| 20 week MA | $116.3 | 23% below |
| 50 week MA | $101.1 | 11% below |
| 100 week MA | $68.0 | 33% above |
| 200 week MA | $51.5 | 75% above |
DOCN has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 75% above its 200-week average.
AMD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $46.2 | $91.8 | +99% |
| 2021 | $91.8 | $146.1 | +59% |
| 2022 | $146.1 | $64.5 | -56% |
| 2023 | $64.5 | $147.4 | +128% |
| 2024 | $147.4 | $125.2 | -15% |
| 2025 | $125.2 | $215.0 | +72% |
| 2026 YTD | $215.0 | $585.3 | +172% |
AMD has the edge over DOCN on returns for 2026, with the stronger performance.
DOCN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $41.6 | $81.3 | +95% |
| 2022 | $81.3 | $24.8 | -70% |
| 2023 | $24.8 | $36.7 | +48% |
| 2024 | $36.7 | $34.9 | -4.8% |
| 2025 | $34.9 | $49.5 | +42% |
| 2026 YTD | $49.5 | $90.1 | +82% |
DOCN has finished higher in three of the last five years. It's up 82% so far in 2026.